Dechert LLP

10/29/2025 | Press release | Distributed by Public on 10/29/2025 14:13

Dechert Advises JH Whitney and Its Controlled Affiliates Sale of Aveanna Healthcare Holding Stock

Dechert advised selling stockholders affiliated with J.H. Whitney Equity Partners (Selling Stockholders) in connection with the secondary public offering of 10,000,000 shares of Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) common stock at a public offering price of US$9.00 per share, and in connection with the sale of an additional 1,500,000 shares of Aveanna Healthcare common stock following the underwriters exercising the entire overallotment of the greenshoe option.

Aveanna Healthcare is not offering any shares of its common stock in the Offering. All net proceeds will go to the Selling Stockholders. The Offering closed on October 23, 2025.

Jefferies and J.P. Morgan are acting as joint lead book-running managers for the Offering. Barclays and RBC Capital Markets are acting as book-running managers for the Offering. BMO Capital Markets, BofA Securities, Truist Securities, Deutsche Bank Securities and PNC Capital Markets LLC are acting as bookrunners for the Offering.

Aveanna Healthcare Holdings Inc. is a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations.

J.H. Whitney was one of the first U.S. private equity firms and is often credited with pioneering the development of the private equity industry.

The Dechert team that advised the Selling Stockholders included corporate partners Gregory Schernecke and Markus Bolsinger along with associates Nicholas Chionchio and James Dorian.

About Dechert

Dechert is the law firm that helps business leaders lead.

For more than 150 years, we have advised clients on critical issues - from high-stakes litigation to first-in-market transaction structures and complex regulatory matters. Our nearly 1,000 lawyers in commercial centers worldwide are immersed in the key sectors we serve - financial services, private capital, real estate, life sciences and technology.

Dechert delivers unwavering partnership so our clients can achieve unprecedented results.

Dechert LLP published this content on October 29, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 29, 2025 at 20:13 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]